Lithuania’s healthcare and Life Sciences sector is enjoying an ever-increasing role in the national economy. Today, it accounts for roughly four percent of the GDP, with a somewhat surprising one percent sourced directly from the budding domestic biotechnology sector.
The review includes insights from the President of Lithuania Dalia Grybauskaite, the Managing Director of Enterprise Lithuania Daina Klepone, and the General Manager of Invest Lithuania Mantas Katinas. Many more notable officials, managers of the leading pharmaceutical companies, and representatives of associations contributed to the article by sharing their opinions.
The founder and managing partner of the Rūta Pumputienė Law Firm and Head of the Local American Working Group, Rūta Pumputienė, was quoted in the article as follows:
“As Lithuania’s population continues to decrease and age, fostering innovation in the public healthcare system has become a necessity, not a luxury.”
The Healthcare & Life Sciences Review is produced by PharmaBoardroom, which is the premier website and reviewer for C-Level executives, consultants, regulators and vendors working in the Healthcare Life Sciences globally.